---
title: "If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295982117.md"
description: "Charles River Laboratories (NYSE:CRL) has outperformed the market over the past 15 years with an annualized return of 15.79%. An initial $100 investment would have grown to $887.92, based on a current stock price of $280.05 and a market capitalization of $14.32 billion. The article highlights the significant impact of compounded returns on long-term cash growth."
datetime: "2026-08-14T22:15:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295982117.md)
  - [en](https://longbridge.com/en/news/295982117.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295982117.md)
generator: "portal-rs"
---

# If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today

Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.07% on an annualized basis producing an average annual return of 15.79%. Currently, Charles River has a market capitalization of $14.32 billion.

**Buying $100 In CRL:** If an investor had bought $100 of CRL stock 15 years ago, it would be worth **$887.92** today based on a price of $280.05 for CRL at the time of writing.

### Charles River’s Performance Over Last 15 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/08/14/08482afa11c95895b522b5468b57464e.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

*This article was generated by Benzinga's automated content engine and reviewed by an editor.*

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)

## Related News & Research

- [Insider Move at Charles River Labs: Director Cashes In on Company Stock](https://longbridge.com/en/news/296571643.md)
- [Charles River Labs director Nancy C. Andrews disposes of 573 common shares worth $163,442.52](https://longbridge.com/en/news/296533503.md)
- [Charles River and MVC to develop enterovirus vaccine](https://longbridge.com/en/news/296594849.md)
- [Charles River partners with Medigen Vaccine Biologics on NGS-backed multivalent enterovirus vaccine development](https://longbridge.com/en/news/296486690.md)
- [Here's How Much $100 Invested In Comfort Systems USA 15 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296544618.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**